UBS O'Connor’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

UBS O'Connor’s Portfolio NKGN Stock Details NKGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-316,204	Closed	-$3.27M	–	696
2023 Q2	$3.27M	Sell	316,204 -3,899	-1%	-$39.9K	0.07%	178
2023 Q1	$3.24M	Buy	+320,103	New	+$3.23M	0.08%	198
2022 Q4	–	Sell	-320,103	Closed	-$3.12M	–	419
2022 Q3	$3.12M	Sell	320,103 -32,585	-9%	-$318K	0.04%	430
2022 Q2	$3.42M	Buy	+352,688	New	+$3.43M	0.04%	437
2022 Q1	–	Sell	-352,688	Closed	-$3.41M	–	300
2021 Q4	$3.41M	Buy	352,688 +1,709	+0.5%	+$16.6K	0.03%	387
2021 Q3	$3.4M	Buy	+350,979	New	+$3.42M	0.03%	403

Other funds holding NKGN

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $382M AUM 31.69% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $574M AUM 6.51% 1-Year Est. Return

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.2B AUM 23.27% 1-Year Est. Return

Mint Tower Capital Management Amsterdam, Netherlands $1.08B AUM 19.06% 1-Year Est. Return

Westchester Capital Management (New York) Valhalla, New York $2.07B AUM 26.02% 1-Year Est. Return